{"nct_id":"NCT00324155","title":"Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma","status":"COMPLETED","status_verified_date":"2014-10","start_date":"2006-08","start_date_type":null,"primary_completion_date":"2011-01","primary_completion_date_type":"ACTUAL","completion_date":"2013-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}